I'm surprised there has been no comment yet about the quarterly...

I'm surprised there has been no comment yet about the quarterly update. OK, so it was fairly brief, but there were a couple of good positives in it.

For a start, the company expects to have sufficient funding to meet operating costs until August next year - not taking into account any royalties received in the mean time. So capital raisings are off the agenda for a fair while at least.

I also like the comments regarding other companies that have finished their own laboratory testing and are now discussing commercial aspects. This I take to mean contract negotiations. Surely, if things have progressed as positively as the announcement implies, this means further production/supply agreements will not be too far away.

Here's hoping anyway.